SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.8 USD | 0.00% |
|
+2.36% | +75.65% |
| May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
| May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Bio Therapeutic Drugs | 0.00% | +2.36% | +75.65% | +908.00% | -76.67% | 1.52B |  | | |
- Stock Market
- Equities
- SYRE Stock
- Charts Spyre Therapeutics, Inc.
- Relative Strength Chart
